nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Sibutramine—obesity	0.143	0.27	CbGbCtD
Avanafil—CYP3A4—Benzphetamine—obesity	0.108	0.204	CbGbCtD
Avanafil—CYP3A4—Bupropion—obesity	0.092	0.174	CbGbCtD
Avanafil—CYP3A4—Orlistat—obesity	0.075	0.142	CbGbCtD
Avanafil—CYP3A4—Cimetidine—obesity	0.0675	0.127	CbGbCtD
Avanafil—CYP3A4—Topiramate—obesity	0.0442	0.0834	CbGbCtD
Avanafil—PDE5A—cGMP effects—KCNMA1—obesity	0.00847	0.0895	CbGpPWpGaD
Avanafil—PDE5A—cGMP effects—PRKG1—obesity	0.00739	0.0781	CbGpPWpGaD
Avanafil—PDE5A—Nitric oxide stimulates guanylate cyclase—KCNMA1—obesity	0.00673	0.0711	CbGpPWpGaD
Avanafil—PDE5A—Nitric oxide stimulates guanylate cyclase—PRKG1—obesity	0.00587	0.062	CbGpPWpGaD
Avanafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS1—obesity	0.00408	0.0431	CbGpPWpGaD
Avanafil—CYP3A4—Irinotecan Pathway—NPC1—obesity	0.00295	0.0311	CbGpPWpGaD
Avanafil—CYP3A4—Felbamate Metabolism—CYP2E1—obesity	0.00287	0.0303	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—KCNMA1—obesity	0.00262	0.0277	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—PRKG1—obesity	0.00229	0.0242	CbGpPWpGaD
Avanafil—CYP3A4—Irinotecan Pathway—CES1—obesity	0.00204	0.0216	CbGpPWpGaD
Avanafil—PDE5A—Nitric oxide stimulates guanylate cyclase—NOS3—obesity	0.00195	0.0206	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—MFN2—obesity	0.00178	0.0188	CbGpPWpGaD
Avanafil—CYP3A4—Liver X Receptor Pathway—SCD—obesity	0.00172	0.0182	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—NOS1—obesity	0.00159	0.0168	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—AKAP1—obesity	0.00135	0.0142	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—GNB3—obesity	0.00133	0.0141	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—GNAS—obesity	0.0013	0.0137	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—APOB—obesity	0.00127	0.0134	CbGpPWpGaD
Avanafil—CYP3A4—Estrogen metabolism—STS—obesity	0.001	0.0106	CbGpPWpGaD
Avanafil—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—obesity	0.000984	0.0104	CbGpPWpGaD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—obesity	0.000964	0.0102	CbGpPWpGaD
Avanafil—Constipation—Diethylpropion—obesity	0.000951	0.00253	CcSEcCtD
Avanafil—Somnolence—Cimetidine—obesity	0.00094	0.0025	CcSEcCtD
Avanafil—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.000934	0.00986	CbGpPWpGaD
Avanafil—Hepatic enzyme increased—Topiramate—obesity	0.00093	0.00248	CcSEcCtD
Avanafil—Nausea—Phendimetrazine—obesity	0.000929	0.00247	CcSEcCtD
Avanafil—Pollakiuria—Sibutramine—obesity	0.000918	0.00244	CcSEcCtD
Avanafil—Asthenia—Phentermine—obesity	0.000917	0.00244	CcSEcCtD
Avanafil—Infestation—Orlistat—obesity	0.000916	0.00244	CcSEcCtD
Avanafil—Infestation NOS—Orlistat—obesity	0.000916	0.00244	CcSEcCtD
Avanafil—Fatigue—Cimetidine—obesity	0.000912	0.00243	CcSEcCtD
Avanafil—Breast disorder—Bupropion—obesity	0.000906	0.00241	CcSEcCtD
Avanafil—Constipation—Cimetidine—obesity	0.000905	0.00241	CcSEcCtD
Avanafil—Weight increased—Sibutramine—obesity	0.000904	0.00241	CcSEcCtD
Avanafil—Nasopharyngitis—Bupropion—obesity	0.000896	0.00239	CcSEcCtD
Avanafil—Musculoskeletal pain—Topiramate—obesity	0.00089	0.00237	CcSEcCtD
Avanafil—Urinary tract infection—Orlistat—obesity	0.00089	0.00237	CcSEcCtD
Avanafil—Gastritis—Bupropion—obesity	0.000887	0.00236	CcSEcCtD
Avanafil—Dizziness—Phenylpropanolamine—obesity	0.000883	0.00235	CcSEcCtD
Avanafil—Diarrhoea—Phentermine—obesity	0.000874	0.00233	CcSEcCtD
Avanafil—PDE5A—Hemostasis—CFD—obesity	0.00087	0.00918	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SH2B1—obesity	0.00087	0.00918	CbGpPWpGaD
Avanafil—Influenza—Bupropion—obesity	0.000866	0.00231	CcSEcCtD
Avanafil—CYP3A4—Liver X Receptor Pathway—SREBF1—obesity	0.000865	0.00913	CbGpPWpGaD
Avanafil—Urinary tract infection—Sibutramine—obesity	0.000861	0.00229	CcSEcCtD
Avanafil—Sinusitis—Orlistat—obesity	0.000859	0.00229	CcSEcCtD
Avanafil—Influenza like illness—Topiramate—obesity	0.000854	0.00227	CcSEcCtD
Avanafil—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—obesity	0.000854	0.00902	CbGpPWpGaD
Avanafil—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.000854	0.00902	CbGpPWpGaD
Avanafil—Vomiting—Phenylpropanolamine—obesity	0.000849	0.00226	CcSEcCtD
Avanafil—Dizziness—Phentermine—obesity	0.000845	0.00225	CcSEcCtD
Avanafil—Haematuria—Sibutramine—obesity	0.000845	0.00225	CcSEcCtD
Avanafil—Rash—Phenylpropanolamine—obesity	0.000842	0.00224	CcSEcCtD
Avanafil—Dermatitis—Phenylpropanolamine—obesity	0.000841	0.00224	CcSEcCtD
Avanafil—Body temperature increased—Cimetidine—obesity	0.000836	0.00223	CcSEcCtD
Avanafil—Epistaxis—Sibutramine—obesity	0.000836	0.00222	CcSEcCtD
Avanafil—Bronchitis—Bupropion—obesity	0.000833	0.00222	CcSEcCtD
Avanafil—Sinusitis—Sibutramine—obesity	0.000831	0.00221	CcSEcCtD
Avanafil—Abdominal discomfort—Bupropion—obesity	0.000831	0.00221	CcSEcCtD
Avanafil—CYP3A4—Liver X Receptor Pathway—FASN—obesity	0.000823	0.00869	CbGpPWpGaD
Avanafil—Vomiting—Phentermine—obesity	0.000812	0.00216	CcSEcCtD
Avanafil—Urinary tract disorder—Orlistat—obesity	0.000812	0.00216	CcSEcCtD
Avanafil—Oedema peripheral—Orlistat—obesity	0.00081	0.00216	CcSEcCtD
Avanafil—Urethral disorder—Orlistat—obesity	0.000806	0.00214	CcSEcCtD
Avanafil—Rash—Phentermine—obesity	0.000806	0.00214	CcSEcCtD
Avanafil—Upper respiratory tract infection—Bupropion—obesity	0.000805	0.00214	CcSEcCtD
Avanafil—Dermatitis—Phentermine—obesity	0.000805	0.00214	CcSEcCtD
Avanafil—Headache—Phentermine—obesity	0.000801	0.00213	CcSEcCtD
Avanafil—Pollakiuria—Bupropion—obesity	0.0008	0.00213	CcSEcCtD
Avanafil—Nausea—Phenylpropanolamine—obesity	0.000793	0.00211	CcSEcCtD
Avanafil—Weight increased—Bupropion—obesity	0.000788	0.0021	CcSEcCtD
Avanafil—Oedema peripheral—Sibutramine—obesity	0.000784	0.00209	CcSEcCtD
Avanafil—Infestation NOS—Bupropion—obesity	0.000772	0.00206	CcSEcCtD
Avanafil—Infestation—Bupropion—obesity	0.000772	0.00206	CcSEcCtD
Avanafil—PDE5A—Platelet homeostasis—NOS3—obesity	0.000761	0.00804	CbGpPWpGaD
Avanafil—Diarrhoea—Diethylpropion—obesity	0.000761	0.00202	CcSEcCtD
Avanafil—Nausea—Phentermine—obesity	0.000759	0.00202	CcSEcCtD
Avanafil—Asthenia—Cimetidine—obesity	0.000759	0.00202	CcSEcCtD
Avanafil—Urinary tract infection—Bupropion—obesity	0.000751	0.002	CcSEcCtD
Avanafil—Eye disorder—Sibutramine—obesity	0.000743	0.00198	CcSEcCtD
Avanafil—Immune system disorder—Orlistat—obesity	0.000742	0.00198	CcSEcCtD
Avanafil—Mediastinal disorder—Orlistat—obesity	0.000741	0.00197	CcSEcCtD
Avanafil—Dizziness—Diethylpropion—obesity	0.000735	0.00196	CcSEcCtD
Avanafil—Diabetes mellitus—Topiramate—obesity	0.000734	0.00195	CcSEcCtD
Avanafil—Epistaxis—Bupropion—obesity	0.000729	0.00194	CcSEcCtD
Avanafil—Sinusitis—Bupropion—obesity	0.000725	0.00193	CcSEcCtD
Avanafil—Diarrhoea—Cimetidine—obesity	0.000724	0.00193	CcSEcCtD
Avanafil—Angiopathy—Sibutramine—obesity	0.000722	0.00192	CcSEcCtD
Avanafil—Mental disorder—Orlistat—obesity	0.00072	0.00192	CcSEcCtD
Avanafil—Immune system disorder—Sibutramine—obesity	0.000718	0.00191	CcSEcCtD
Avanafil—Malnutrition—Orlistat—obesity	0.000716	0.0019	CcSEcCtD
Avanafil—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.000708	0.00747	CbGpPWpGaD
Avanafil—Vomiting—Diethylpropion—obesity	0.000707	0.00188	CcSEcCtD
Avanafil—Nasal congestion—Topiramate—obesity	0.000701	0.00187	CcSEcCtD
Avanafil—Rash—Diethylpropion—obesity	0.000701	0.00187	CcSEcCtD
Avanafil—Dermatitis—Diethylpropion—obesity	0.0007	0.00186	CcSEcCtD
Avanafil—Dizziness—Cimetidine—obesity	0.000699	0.00186	CcSEcCtD
Avanafil—Headache—Diethylpropion—obesity	0.000696	0.00185	CcSEcCtD
Avanafil—Malnutrition—Sibutramine—obesity	0.000692	0.00184	CcSEcCtD
Avanafil—Back pain—Orlistat—obesity	0.000692	0.00184	CcSEcCtD
Avanafil—Muscle spasms—Orlistat—obesity	0.000688	0.00183	CcSEcCtD
Avanafil—Urinary tract disorder—Bupropion—obesity	0.000685	0.00182	CcSEcCtD
Avanafil—Oedema peripheral—Bupropion—obesity	0.000683	0.00182	CcSEcCtD
Avanafil—Hot flush—Topiramate—obesity	0.000683	0.00182	CcSEcCtD
Avanafil—PDE5A—Hemostasis—PRKCH—obesity	0.000682	0.00721	CbGpPWpGaD
Avanafil—Connective tissue disorder—Bupropion—obesity	0.000681	0.00181	CcSEcCtD
Avanafil—Urethral disorder—Bupropion—obesity	0.00068	0.00181	CcSEcCtD
Avanafil—Menopausal symptoms—Topiramate—obesity	0.000677	0.0018	CcSEcCtD
Avanafil—Vision blurred—Orlistat—obesity	0.000674	0.00179	CcSEcCtD
Avanafil—Vomiting—Cimetidine—obesity	0.000673	0.00179	CcSEcCtD
Avanafil—Back pain—Sibutramine—obesity	0.00067	0.00178	CcSEcCtD
Avanafil—Rash—Cimetidine—obesity	0.000667	0.00178	CcSEcCtD
Avanafil—Dermatitis—Cimetidine—obesity	0.000666	0.00177	CcSEcCtD
Avanafil—Muscle spasms—Sibutramine—obesity	0.000666	0.00177	CcSEcCtD
Avanafil—Headache—Cimetidine—obesity	0.000663	0.00176	CcSEcCtD
Avanafil—Nausea—Diethylpropion—obesity	0.00066	0.00176	CcSEcCtD
Avanafil—Hypoglycaemia—Topiramate—obesity	0.000654	0.00174	CcSEcCtD
Avanafil—Vision blurred—Sibutramine—obesity	0.000653	0.00174	CcSEcCtD
Avanafil—Eye disorder—Bupropion—obesity	0.000648	0.00173	CcSEcCtD
Avanafil—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—obesity	0.000647	0.00684	CbGpPWpGaD
Avanafil—Flushing—Bupropion—obesity	0.000644	0.00171	CcSEcCtD
Avanafil—Cardiac disorder—Bupropion—obesity	0.000644	0.00171	CcSEcCtD
Avanafil—Vertigo—Orlistat—obesity	0.000643	0.00171	CcSEcCtD
Avanafil—Pain in extremity—Topiramate—obesity	0.000639	0.0017	CcSEcCtD
Avanafil—Agitation—Sibutramine—obesity	0.000636	0.00169	CcSEcCtD
Avanafil—Palpitations—Orlistat—obesity	0.000632	0.00168	CcSEcCtD
Avanafil—Angiopathy—Bupropion—obesity	0.000629	0.00167	CcSEcCtD
Avanafil—Nausea—Cimetidine—obesity	0.000628	0.00167	CcSEcCtD
Avanafil—Immune system disorder—Bupropion—obesity	0.000626	0.00167	CcSEcCtD
Avanafil—CYP3A4—Irinotecan Pathway—BCHE—obesity	0.000626	0.00661	CbGpPWpGaD
Avanafil—Mediastinal disorder—Bupropion—obesity	0.000625	0.00166	CcSEcCtD
Avanafil—Cough—Orlistat—obesity	0.000624	0.00166	CcSEcCtD
Avanafil—Vertigo—Sibutramine—obesity	0.000622	0.00166	CcSEcCtD
Avanafil—Palpitations—Sibutramine—obesity	0.000612	0.00163	CcSEcCtD
Avanafil—Myalgia—Orlistat—obesity	0.000609	0.00162	CcSEcCtD
Avanafil—Chest pain—Orlistat—obesity	0.000609	0.00162	CcSEcCtD
Avanafil—Mental disorder—Bupropion—obesity	0.000608	0.00162	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000605	0.00161	CcSEcCtD
Avanafil—Cough—Sibutramine—obesity	0.000604	0.00161	CcSEcCtD
Avanafil—Malnutrition—Bupropion—obesity	0.000604	0.00161	CcSEcCtD
Avanafil—Blood creatinine increased—Topiramate—obesity	0.000598	0.00159	CcSEcCtD
Avanafil—Hypertension—Sibutramine—obesity	0.000598	0.00159	CcSEcCtD
Avanafil—CYP3A4—Tamoxifen metabolism—SULT2A1—obesity	0.000598	0.00631	CbGpPWpGaD
Avanafil—Dry mouth—Orlistat—obesity	0.000596	0.00159	CcSEcCtD
Avanafil—Chest pain—Sibutramine—obesity	0.00059	0.00157	CcSEcCtD
Avanafil—Arthralgia—Sibutramine—obesity	0.00059	0.00157	CcSEcCtD
Avanafil—Myalgia—Sibutramine—obesity	0.00059	0.00157	CcSEcCtD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	0.000589	0.00622	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—KCNMA1—obesity	0.000587	0.0062	CbGpPWpGaD
Avanafil—Back pain—Bupropion—obesity	0.000584	0.00155	CcSEcCtD
Avanafil—Muscle spasms—Bupropion—obesity	0.00058	0.00154	CcSEcCtD
Avanafil—Infection—Orlistat—obesity	0.00058	0.00154	CcSEcCtD
Avanafil—Breast disorder—Topiramate—obesity	0.000577	0.00154	CcSEcCtD
Avanafil—Dry mouth—Sibutramine—obesity	0.000577	0.00153	CcSEcCtD
Avanafil—Nervous system disorder—Orlistat—obesity	0.000573	0.00152	CcSEcCtD
Avanafil—Nasopharyngitis—Topiramate—obesity	0.000571	0.00152	CcSEcCtD
Avanafil—Vision blurred—Bupropion—obesity	0.000569	0.00151	CcSEcCtD
Avanafil—Skin disorder—Orlistat—obesity	0.000567	0.00151	CcSEcCtD
Avanafil—Gastritis—Topiramate—obesity	0.000565	0.0015	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Topiramate—obesity	0.000563	0.0015	CcSEcCtD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—obesity	0.000563	0.00594	CbGpPWpGaD
Avanafil—Infection—Sibutramine—obesity	0.000561	0.00149	CcSEcCtD
Avanafil—Agitation—Bupropion—obesity	0.000555	0.00148	CcSEcCtD
Avanafil—Tachycardia—Sibutramine—obesity	0.000552	0.00147	CcSEcCtD
Avanafil—Skin disorder—Sibutramine—obesity	0.000549	0.00146	CcSEcCtD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—obesity	0.000543	0.00573	CbGpPWpGaD
Avanafil—Vertigo—Bupropion—obesity	0.000542	0.00144	CcSEcCtD
Avanafil—Angina pectoris—Topiramate—obesity	0.000538	0.00143	CcSEcCtD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	0.000536	0.00566	CbGpPWpGaD
Avanafil—Palpitations—Bupropion—obesity	0.000533	0.00142	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Orlistat—obesity	0.000532	0.00142	CcSEcCtD
Avanafil—Bronchitis—Topiramate—obesity	0.000531	0.00141	CcSEcCtD
Avanafil—Abdominal discomfort—Topiramate—obesity	0.000529	0.00141	CcSEcCtD
Avanafil—Insomnia—Orlistat—obesity	0.000528	0.00141	CcSEcCtD
Avanafil—Hypotension—Sibutramine—obesity	0.000528	0.00141	CcSEcCtD
Avanafil—Cough—Bupropion—obesity	0.000527	0.0014	CcSEcCtD
Avanafil—Hypertension—Bupropion—obesity	0.000521	0.00139	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Sibutramine—obesity	0.000515	0.00137	CcSEcCtD
Avanafil—Dyspepsia—Orlistat—obesity	0.000514	0.00137	CcSEcCtD
Avanafil—Arthralgia—Bupropion—obesity	0.000514	0.00137	CcSEcCtD
Avanafil—Myalgia—Bupropion—obesity	0.000514	0.00137	CcSEcCtD
Avanafil—Chest pain—Bupropion—obesity	0.000514	0.00137	CcSEcCtD
Avanafil—Upper respiratory tract infection—Topiramate—obesity	0.000513	0.00137	CcSEcCtD
Avanafil—PDE5A—Hemostasis—PRKG1—obesity	0.000513	0.00541	CbGpPWpGaD
Avanafil—Insomnia—Sibutramine—obesity	0.000511	0.00136	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00051	0.00136	CcSEcCtD
Avanafil—Pollakiuria—Topiramate—obesity	0.00051	0.00136	CcSEcCtD
Avanafil—Gastrointestinal disorder—Orlistat—obesity	0.000504	0.00134	CcSEcCtD
Avanafil—Fatigue—Orlistat—obesity	0.000503	0.00134	CcSEcCtD
Avanafil—Dry mouth—Bupropion—obesity	0.000503	0.00134	CcSEcCtD
Avanafil—Somnolence—Sibutramine—obesity	0.000502	0.00134	CcSEcCtD
Avanafil—Weight increased—Topiramate—obesity	0.000502	0.00134	CcSEcCtD
Avanafil—Dyspepsia—Sibutramine—obesity	0.000497	0.00132	CcSEcCtD
Avanafil—Infestation NOS—Topiramate—obesity	0.000492	0.00131	CcSEcCtD
Avanafil—Infestation—Topiramate—obesity	0.000492	0.00131	CcSEcCtD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—obesity	0.00049	0.00518	CbGpPWpGaD
Avanafil—Infection—Bupropion—obesity	0.000489	0.0013	CcSEcCtD
Avanafil—CYP3A4—Estrogen metabolism—NQO1—obesity	0.000489	0.00516	CbGpPWpGaD
Avanafil—Gastrointestinal disorder—Sibutramine—obesity	0.000488	0.0013	CcSEcCtD
Avanafil—Constipation—Sibutramine—obesity	0.000483	0.00129	CcSEcCtD
Avanafil—Nervous system disorder—Bupropion—obesity	0.000483	0.00129	CcSEcCtD
Avanafil—Tachycardia—Bupropion—obesity	0.000481	0.00128	CcSEcCtD
Avanafil—Skin disorder—Bupropion—obesity	0.000479	0.00127	CcSEcCtD
Avanafil—Urinary tract infection—Topiramate—obesity	0.000478	0.00127	CcSEcCtD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYB5A—obesity	0.000477	0.00503	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PRKAR2B—obesity	0.000473	0.00499	CbGpPWpGaD
Avanafil—Haematuria—Topiramate—obesity	0.000469	0.00125	CcSEcCtD
Avanafil—Epistaxis—Topiramate—obesity	0.000464	0.00124	CcSEcCtD
Avanafil—Sinusitis—Topiramate—obesity	0.000462	0.00123	CcSEcCtD
Avanafil—Body temperature increased—Orlistat—obesity	0.000462	0.00123	CcSEcCtD
Avanafil—Hypotension—Bupropion—obesity	0.00046	0.00123	CcSEcCtD
Avanafil—CYP3A4—Xenobiotics—CYP2E1—obesity	0.000454	0.0048	CbGpPWpGaD
Avanafil—Musculoskeletal discomfort—Bupropion—obesity	0.000449	0.00119	CcSEcCtD
Avanafil—Body temperature increased—Sibutramine—obesity	0.000447	0.00119	CcSEcCtD
Avanafil—Insomnia—Bupropion—obesity	0.000446	0.00119	CcSEcCtD
Avanafil—Somnolence—Bupropion—obesity	0.000438	0.00117	CcSEcCtD
Avanafil—CYP3A4—Tamoxifen metabolism—CYP2E1—obesity	0.000437	0.00461	CbGpPWpGaD
Avanafil—Urinary tract disorder—Topiramate—obesity	0.000436	0.00116	CcSEcCtD
Avanafil—Oedema peripheral—Topiramate—obesity	0.000435	0.00116	CcSEcCtD
Avanafil—CYP3A4—Aflatoxin activation and detoxification—GGT1—obesity	0.000435	0.00459	CbGpPWpGaD
Avanafil—Connective tissue disorder—Topiramate—obesity	0.000434	0.00116	CcSEcCtD
Avanafil—Dyspepsia—Bupropion—obesity	0.000434	0.00115	CcSEcCtD
Avanafil—Urethral disorder—Topiramate—obesity	0.000433	0.00115	CcSEcCtD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	0.000427	0.0045	CbGpPWpGaD
Avanafil—Gastrointestinal disorder—Bupropion—obesity	0.000425	0.00113	CcSEcCtD
Avanafil—Fatigue—Bupropion—obesity	0.000425	0.00113	CcSEcCtD
Avanafil—PDE5A—Hemostasis—TF—obesity	0.000425	0.00448	CbGpPWpGaD
Avanafil—Constipation—Bupropion—obesity	0.000421	0.00112	CcSEcCtD
Avanafil—CYP3A4—Tryptophan metabolism—ECHS1—obesity	0.000421	0.00445	CbGpPWpGaD
Avanafil—Asthenia—Orlistat—obesity	0.000419	0.00112	CcSEcCtD
Avanafil—Pruritus—Orlistat—obesity	0.000413	0.0011	CcSEcCtD
Avanafil—Eye disorder—Topiramate—obesity	0.000413	0.0011	CcSEcCtD
Avanafil—Cardiac disorder—Topiramate—obesity	0.00041	0.00109	CcSEcCtD
Avanafil—Flushing—Topiramate—obesity	0.00041	0.00109	CcSEcCtD
Avanafil—CYP3A4—Estrogen metabolism—COMT—obesity	0.00041	0.00432	CbGpPWpGaD
Avanafil—Asthenia—Sibutramine—obesity	0.000405	0.00108	CcSEcCtD
Avanafil—Angiopathy—Topiramate—obesity	0.000401	0.00107	CcSEcCtD
Avanafil—Pruritus—Sibutramine—obesity	0.0004	0.00106	CcSEcCtD
Avanafil—Diarrhoea—Orlistat—obesity	0.0004	0.00106	CcSEcCtD
Avanafil—Immune system disorder—Topiramate—obesity	0.000399	0.00106	CcSEcCtD
Avanafil—Mediastinal disorder—Topiramate—obesity	0.000398	0.00106	CcSEcCtD
Avanafil—CYP3A4—Tryptophan metabolism—HADH—obesity	0.000396	0.00418	CbGpPWpGaD
Avanafil—Body temperature increased—Bupropion—obesity	0.000389	0.00104	CcSEcCtD
Avanafil—Mental disorder—Topiramate—obesity	0.000387	0.00103	CcSEcCtD
Avanafil—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—obesity	0.000387	0.00408	CbGpPWpGaD
Avanafil—Diarrhoea—Sibutramine—obesity	0.000387	0.00103	CcSEcCtD
Avanafil—Dizziness—Orlistat—obesity	0.000386	0.00103	CcSEcCtD
Avanafil—Malnutrition—Topiramate—obesity	0.000385	0.00102	CcSEcCtD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—obesity	0.000382	0.00403	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—obesity	0.000377	0.00398	CbGpPWpGaD
Avanafil—Dizziness—Sibutramine—obesity	0.000374	0.000995	CcSEcCtD
Avanafil—Back pain—Topiramate—obesity	0.000372	0.00099	CcSEcCtD
Avanafil—Vomiting—Orlistat—obesity	0.000371	0.000988	CcSEcCtD
Avanafil—Muscle spasms—Topiramate—obesity	0.00037	0.000984	CcSEcCtD
Avanafil—Rash—Orlistat—obesity	0.000368	0.00098	CcSEcCtD
Avanafil—Dermatitis—Orlistat—obesity	0.000368	0.000979	CcSEcCtD
Avanafil—Headache—Orlistat—obesity	0.000366	0.000974	CcSEcCtD
Avanafil—Vision blurred—Topiramate—obesity	0.000362	0.000965	CcSEcCtD
Avanafil—Vomiting—Sibutramine—obesity	0.000359	0.000956	CcSEcCtD
Avanafil—Rash—Sibutramine—obesity	0.000356	0.000949	CcSEcCtD
Avanafil—Dermatitis—Sibutramine—obesity	0.000356	0.000948	CcSEcCtD
Avanafil—PDE5A—Hemostasis—NOS1—obesity	0.000356	0.00376	CbGpPWpGaD
Avanafil—Headache—Sibutramine—obesity	0.000354	0.000942	CcSEcCtD
Avanafil—Asthenia—Bupropion—obesity	0.000353	0.000941	CcSEcCtD
Avanafil—Agitation—Topiramate—obesity	0.000353	0.000941	CcSEcCtD
Avanafil—Pruritus—Bupropion—obesity	0.000349	0.000928	CcSEcCtD
Avanafil—Nausea—Orlistat—obesity	0.000347	0.000923	CcSEcCtD
Avanafil—PDE5A—Hemostasis—PTPN1—obesity	0.000346	0.00366	CbGpPWpGaD
Avanafil—Vertigo—Topiramate—obesity	0.000346	0.00092	CcSEcCtD
Avanafil—Palpitations—Topiramate—obesity	0.00034	0.000905	CcSEcCtD
Avanafil—Diarrhoea—Bupropion—obesity	0.000337	0.000897	CcSEcCtD
Avanafil—Nausea—Sibutramine—obesity	0.000336	0.000894	CcSEcCtD
Avanafil—Cough—Topiramate—obesity	0.000336	0.000893	CcSEcCtD
Avanafil—Hypertension—Topiramate—obesity	0.000332	0.000884	CcSEcCtD
Avanafil—Chest pain—Topiramate—obesity	0.000327	0.000872	CcSEcCtD
Avanafil—Myalgia—Topiramate—obesity	0.000327	0.000872	CcSEcCtD
Avanafil—Arthralgia—Topiramate—obesity	0.000327	0.000872	CcSEcCtD
Avanafil—Dizziness—Bupropion—obesity	0.000326	0.000867	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000325	0.000866	CcSEcCtD
Avanafil—PDE5A—Hemostasis—PLG—obesity	0.000322	0.0034	CbGpPWpGaD
Avanafil—Dry mouth—Topiramate—obesity	0.00032	0.000852	CcSEcCtD
Avanafil—Vomiting—Bupropion—obesity	0.000313	0.000834	CcSEcCtD
Avanafil—Infection—Topiramate—obesity	0.000312	0.00083	CcSEcCtD
Avanafil—Rash—Bupropion—obesity	0.000311	0.000827	CcSEcCtD
Avanafil—Dermatitis—Bupropion—obesity	0.00031	0.000826	CcSEcCtD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	0.00031	0.00327	CbGpPWpGaD
Avanafil—Headache—Bupropion—obesity	0.000309	0.000822	CcSEcCtD
Avanafil—Nervous system disorder—Topiramate—obesity	0.000308	0.000819	CcSEcCtD
Avanafil—Tachycardia—Topiramate—obesity	0.000306	0.000815	CcSEcCtD
Avanafil—Skin disorder—Topiramate—obesity	0.000305	0.000812	CcSEcCtD
Avanafil—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	0.000302	0.00318	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—GNB3—obesity	0.000298	0.00315	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	0.000297	0.00314	CbGpPWpGaD
Avanafil—Hypotension—Topiramate—obesity	0.000293	0.000781	CcSEcCtD
Avanafil—PDE5A—Hemostasis—IGF2—obesity	0.000293	0.00309	CbGpPWpGaD
Avanafil—Nausea—Bupropion—obesity	0.000293	0.000779	CcSEcCtD
Avanafil—PDE5A—Hemostasis—GNAS—obesity	0.000291	0.00307	CbGpPWpGaD
Avanafil—Musculoskeletal discomfort—Topiramate—obesity	0.000286	0.000761	CcSEcCtD
Avanafil—PDE5A—Hemostasis—APOB—obesity	0.000285	0.003	CbGpPWpGaD
Avanafil—Insomnia—Topiramate—obesity	0.000284	0.000756	CcSEcCtD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	0.000282	0.00298	CbGpPWpGaD
Avanafil—Somnolence—Topiramate—obesity	0.000279	0.000743	CcSEcCtD
Avanafil—Dyspepsia—Topiramate—obesity	0.000276	0.000735	CcSEcCtD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	0.000272	0.00287	CbGpPWpGaD
Avanafil—Gastrointestinal disorder—Topiramate—obesity	0.000271	0.000721	CcSEcCtD
Avanafil—Fatigue—Topiramate—obesity	0.000271	0.00072	CcSEcCtD
Avanafil—Constipation—Topiramate—obesity	0.000268	0.000715	CcSEcCtD
Avanafil—PDE5A—Hemostasis—CD36—obesity	0.000258	0.00273	CbGpPWpGaD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	0.000255	0.00269	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PRKCD—obesity	0.00025	0.00264	CbGpPWpGaD
Avanafil—Body temperature increased—Topiramate—obesity	0.000248	0.000661	CcSEcCtD
Avanafil—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	0.000233	0.00246	CbGpPWpGaD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	0.00023	0.00243	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—CAV1—obesity	0.000226	0.00238	CbGpPWpGaD
Avanafil—Asthenia—Topiramate—obesity	0.000225	0.000599	CcSEcCtD
Avanafil—PDE5A—Hemostasis—APOA1—obesity	0.000225	0.00238	CbGpPWpGaD
Avanafil—Pruritus—Topiramate—obesity	0.000222	0.000591	CcSEcCtD
Avanafil—Diarrhoea—Topiramate—obesity	0.000215	0.000572	CcSEcCtD
Avanafil—PDE5A—Hemostasis—PRKCB—obesity	0.000215	0.00227	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—F2—obesity	0.000215	0.00227	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	0.000208	0.0022	CbGpPWpGaD
Avanafil—Dizziness—Topiramate—obesity	0.000208	0.000553	CcSEcCtD
Avanafil—PDE5A—Hemostasis—PIK3CG—obesity	0.000206	0.00217	CbGpPWpGaD
Avanafil—Vomiting—Topiramate—obesity	0.0002	0.000531	CcSEcCtD
Avanafil—Rash—Topiramate—obesity	0.000198	0.000527	CcSEcCtD
Avanafil—Dermatitis—Topiramate—obesity	0.000198	0.000526	CcSEcCtD
Avanafil—Headache—Topiramate—obesity	0.000197	0.000523	CcSEcCtD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	0.000195	0.00206	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	0.000189	0.00199	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—IGF1—obesity	0.000188	0.00199	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—AKT2—obesity	0.000188	0.00199	CbGpPWpGaD
Avanafil—Nausea—Topiramate—obesity	0.000186	0.000496	CcSEcCtD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	0.000186	0.00197	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PIK3CD—obesity	0.000181	0.00191	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—SERPINE1—obesity	0.000179	0.00189	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ALB—obesity	0.000178	0.00188	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—RHOA—obesity	0.000172	0.00182	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	0.000171	0.0018	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PIK3R1—obesity	0.000171	0.0018	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—NOS3—obesity	0.000171	0.0018	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	0.000168	0.00178	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	0.000166	0.00175	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP26B1—obesity	0.000164	0.00174	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	0.000162	0.00171	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	0.000161	0.0017	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PIK3CB—obesity	0.000157	0.00166	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	0.000153	0.00161	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ADH1B—obesity	0.000144	0.00152	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	0.000138	0.00146	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	0.000136	0.00144	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—TGFB1—obesity	0.000113	0.00119	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—SULT2A1—obesity	0.000111	0.00117	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	0.00011	0.00116	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GPX3—obesity	0.000105	0.0011	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	0.000101	0.00107	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PIK3CA—obesity	9.6e-05	0.00101	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	9.17e-05	0.000968	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	8.19e-05	0.000865	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP2E1—obesity	8.12e-05	0.000858	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	8.01e-05	0.000846	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—AKT1—obesity	7.84e-05	0.000828	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GGT1—obesity	7.46e-05	0.000787	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—NCOA1—obesity	7.35e-05	0.000776	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP19A1—obesity	7.24e-05	0.000764	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	7.14e-05	0.000754	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CA3—obesity	6.77e-05	0.000715	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—COMT—obesity	6.73e-05	0.000711	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—COMT—obesity	6.64e-05	0.000701	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GLRX—obesity	5.76e-05	0.000608	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—OTC—obesity	5.13e-05	0.000542	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—INSIG2—obesity	5.13e-05	0.000542	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ETFDH—obesity	5.13e-05	0.000542	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPM1L—obesity	5.13e-05	0.000542	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—INPP5E—obesity	4.7e-05	0.000496	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—UQCRC2—obesity	4.7e-05	0.000496	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GPT—obesity	4.7e-05	0.000496	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ME1—obesity	4.36e-05	0.000461	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SUCLG2—obesity	4.36e-05	0.000461	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALDH6A1—obesity	4.36e-05	0.000461	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—POMC—obesity	4.35e-05	0.000459	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—COX7C—obesity	4.1e-05	0.000433	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PNPLA3—obesity	4.1e-05	0.000433	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—UCP1—obesity	4.1e-05	0.000433	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CS—obesity	3.89e-05	0.000411	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—DGAT2—obesity	3.89e-05	0.000411	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CPS1—obesity	3.89e-05	0.000411	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SUCLA2—obesity	3.89e-05	0.000411	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LIPE—obesity	3.71e-05	0.000392	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—MUT—obesity	3.71e-05	0.000392	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—DGAT1—obesity	3.56e-05	0.000376	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYB5A—obesity	3.56e-05	0.000376	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ACLY—obesity	3.43e-05	0.000362	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ENPP1—obesity	3.31e-05	0.000349	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALOX12—obesity	3.31e-05	0.000349	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HMGCS1—obesity	3.2e-05	0.000338	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PNPLA2—obesity	3.11e-05	0.000328	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ACADM—obesity	3.11e-05	0.000328	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PFKFB3—obesity	3.11e-05	0.000328	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ANGPTL4—obesity	3.11e-05	0.000328	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SAT1—obesity	3.11e-05	0.000328	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PLIN1—obesity	3.11e-05	0.000328	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYTB—obesity	3.03e-05	0.000319	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ACACB—obesity	3.03e-05	0.000319	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—OXCT1—obesity	3.03e-05	0.000319	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SRD5A1—obesity	2.95e-05	0.000311	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PNLIP—obesity	2.95e-05	0.000311	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SDC3—obesity	2.88e-05	0.000304	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP26B1—obesity	2.81e-05	0.000297	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—STS—obesity	2.81e-05	0.000297	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HK2—obesity	2.81e-05	0.000297	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARD—obesity	2.75e-05	0.000291	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC27A1—obesity	2.7e-05	0.000285	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—FABP4—obesity	2.64e-05	0.000279	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GLUL—obesity	2.64e-05	0.000279	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HSD11B1—obesity	2.51e-05	0.000265	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—UCP3—obesity	2.51e-05	0.000265	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ECHS1—obesity	2.51e-05	0.000265	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—UCP2—obesity	2.51e-05	0.000265	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ADH1B—obesity	2.47e-05	0.00026	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GPAM—obesity	2.43e-05	0.000256	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARGC1B—obesity	2.43e-05	0.000256	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ACSL1—obesity	2.43e-05	0.000256	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HADH—obesity	2.36e-05	0.000249	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—FADS1—obesity	2.36e-05	0.000249	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PCK1—obesity	2.36e-05	0.000249	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ACP5—obesity	2.29e-05	0.000242	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—G6PD—obesity	2.23e-05	0.000236	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SREBF2—obesity	2.21e-05	0.000233	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HK1—obesity	2.21e-05	0.000233	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LPA—obesity	2.13e-05	0.000225	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LPIN1—obesity	2.09e-05	0.00022	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOA5—obesity	2.04e-05	0.000216	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CLOCK—obesity	1.95e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC22A1—obesity	1.95e-05	0.000206	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SULT2A1—obesity	1.9e-05	0.000201	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GLP1R—obesity	1.9e-05	0.000201	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—DPYD—obesity	1.87e-05	0.000197	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PRKAR2B—obesity	1.8e-05	0.00019	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—DCN—obesity	1.79e-05	0.000189	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CPT1A—obesity	1.74e-05	0.000183	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—NAMPT—obesity	1.7e-05	0.00018	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LIPC—obesity	1.69e-05	0.000179	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GCK—obesity	1.69e-05	0.000179	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOC3—obesity	1.68e-05	0.000178	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CETP—obesity	1.63e-05	0.000173	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SDC1—obesity	1.62e-05	0.000171	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AKR1C3—obesity	1.59e-05	0.000168	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SCARB1—obesity	1.56e-05	0.000165	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SREBF1—obesity	1.52e-05	0.00016	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GOT2—obesity	1.48e-05	0.000156	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—FASN—obesity	1.45e-05	0.000153	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—BCHE—obesity	1.44e-05	0.000152	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP2E1—obesity	1.39e-05	0.000147	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—NQO1—obesity	1.37e-05	0.000145	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC2A4—obesity	1.32e-05	0.000139	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GCG—obesity	1.32e-05	0.000139	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYCS—obesity	1.3e-05	0.000137	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GOT1—obesity	1.28e-05	0.000135	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GGT1—obesity	1.28e-05	0.000135	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—NCOA1—obesity	1.26e-05	0.000133	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—STK11—obesity	1.24e-05	0.000131	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP19A1—obesity	1.24e-05	0.000131	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—COMT—obesity	1.15e-05	0.000122	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARGC1A—obesity	1.14e-05	0.00012	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GNB3—obesity	1.14e-05	0.00012	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—HMOX1—obesity	1.13e-05	0.000119	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GNAS—obesity	1.11e-05	0.000117	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOB—obesity	1.08e-05	0.000114	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LPL—obesity	1.03e-05	0.000109	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GPX1—obesity	1.01e-05	0.000106	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CD36—obesity	9.82e-06	0.000104	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—MTHFR—obesity	9.3e-06	9.82e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARA—obesity	9.13e-06	9.64e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AGT—obesity	8.84e-06	9.33e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOE—obesity	8.66e-06	9.15e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CAV1—obesity	8.58e-06	9.06e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APOA1—obesity	8.56e-06	9.04e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3CG—obesity	7.82e-06	8.25e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPARG—obesity	7.55e-06	7.97e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—POMC—obesity	7.44e-06	7.86e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—INS—obesity	7.4e-06	7.81e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3CD—obesity	6.87e-06	7.26e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALB—obesity	6.78e-06	7.16e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—NOS3—obesity	6.49e-06	6.85e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3R1—obesity	6.49e-06	6.85e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3CB—obesity	5.99e-06	6.32e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTGS2—obesity	5.94e-06	6.27e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3CA—obesity	3.65e-06	3.86e-05	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—AKT1—obesity	2.98e-06	3.15e-05	CbGpPWpGaD
